Get the latest on Avidity Biosciences' late-stage RNA drug pipeline, upcoming FDA filings, and market opportunities for rare muscle diseases.

Get the latest on Annexon’s trailblazing therapies for GBS and GA, regulatory milestones, and upcoming data readouts.